Miriplatin
Miriplatin (SM-11355) is a derivative of cisplatin containing myristates as a carrier ligand. It is a novel lipophilic platinum complex developed to treat hepatocellular carcinoma.DMSO is not recommended to dissolve platinum-based drugs, which can easily lead to drug inactivation.
| Trivial name | SM-11355 |
| Catalog Number | S5024 |
| Molecular Formula | C30H48O4 |
| CAS# | 141977-79-9 |
| Inchi | InChI=1S/C30H48O4/c1-18(2)19-9-14-30(25(33)34)16-15-28(5)20(24(19)30)7-8-22-26(3)12-11-23(32)27(4,17-31)21(26)10-13-29(22,28)6/h19-24,31-32H,1,7-17H2,2-6H3,(H,33,34)/t19-,20+,21+,22+,23-,24+,26-,27-,2 8+,29+,30-/m0/s1 |
| Inchi Key | HXWLKAXCQLXHML-WGOZWDAUSA-N |
| SMILES | CC(=C)C1CCC2(C1C3CCC4C5(CCC(C(C5CCC4(C3(CC2)C)C)(C)CO)O)C)C(=O)O |
| Size | 25mg |
| Supplier Page | http://www.selleckchem.com/products/miriplatin.html |
| Additional Information | https://file.selleck.cn/downloads/struct/miriplatin-chemical-structure-s5024.gif |